Kevin Tang
@Tang Capital Management Llc
Latest period2024 - Q3ReportedManaged Assets$1.4BTotal holdings154
Assets growth rate42.57%Assets growth rate (2-Q avg)22.41%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Tang Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 154 positions.
Assets under management
The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.4B in assets, with a quarterly growth rate of 42.57% and a 2-quarter average growth rate of 22.41%. The portfolio is managed by Kevin Tang, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BNTXBiontech Se
| 2.3% | $32.068M 270,000 shares@ $118.77 avg price | New Position |
RLAYRelay Therapeutics Inc
| 1.81% | $25.262M 3.568M shares@ $7.09 avg price | New Position |
ITOSIteos Therapeutics Inc
| 1.76% | $24.584M 2.408M shares@ $10.21 avg price | New Position |
NBIXNeurocrine Biosciences Inc
| 1.24% | $17.283M 150,000 shares@ $115.22 avg price | New Position |
NVAXNovavax Inc
| 0.91% | $12.63M 1M shares@ $12.63 avg price | New Position |
CRBPCorbus Pharmaceuticals Hldgs
| 0.89% | $12.378M 600,000 shares@ $20.63 avg price | New Position |
ELANElanco Animal Health Inc
| 0.63% | $8.814M 600,000 shares@ $14.69 avg price | New Position |
HLVXHillevax Inc
| 0.62% | $8.659M 4.92M shares@ $1.76 avg price | New Position |
ALXOAlx Oncology Hldgs Inc
| 0.55% | $7.653M 4.205M shares@ $1.83 avg price | New Position |
BLCOBausch Plus Lomb Corp
| 0.49% | $6.752M 350,000 shares@ $19.29 avg price | New Position |